Randi B.
- Country
- Denmark
- Department
- NA
Research Overview
- A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk
- Evaluation of ODM-111 and Paracetamol in the Management of Chronic Pain Associated with Knee Osteoarthritis: A Randomized Controlled Trial
- A phase 2 randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of topical AT-004 1% in the participants with acne vulgaris.
Data & Insights
Has run more than one trial at 5 of 187 partner sites.
Specializations
Cardiovascular disease and lipid disorders
Randi Brechmann is involved in clinical research focused on atherosclerotic cardiovascular disease, high cardiovascular risk, and prevention of major adverse cardiovascular events. This includes work in lipoprotein(a) reduction, cholesterol-lowering therapy, hypertension, and broader cardiometabolic risk management.
- ASCVD and primary prevention
- Elevated Lp(a) and lipoprotein disorders
- Cardiovascular event prevention
- Hypertension and high-risk vascular disease
The therapeutic focus also extends to obesity-associated cardiovascular risk and treatments aimed at reducing cardiovascular morbidity and mortality.
Musculoskeletal pain and osteoarthritis
Her clinical trial activity includes a strong interest in knee osteoarthritis, chronic joint pain, and related functional impairment. The research landscape also covers rotator cuff tendinopathy, knee synovitis, and other painful degenerative joint conditions.
- Knee osteoarthritis
- Chronic pain and symptom control
- Rotator cuff tendinopathy
- Joint structure and function
Therapeutic interests also include interventions for pain relief, mobility, and cartilage-related joint disease.
Inflammatory and immune-mediated diseases
Randi Brechmann is active in studies of atopic dermatitis, psoriasis, polymyalgia rheumatica, rheumatoid arthritis, and other immune-mediated inflammatory disorders. This work also includes dermatologic conditions such as pruritus and vitiligo.
- Atopic dermatitis
- Plaque psoriasis
- Polymyalgia rheumatica
- Rheumatoid arthritis and vitiligo
The therapeutic emphasis is on immune modulation and management of chronic inflammatory skin and rheumatic disease.
Weight management and metabolic disease
Her research portfolio includes obesity, overweight, type 2 diabetes mellitus, and combined cardiometabolic and musculoskeletal conditions. Trial activity also reflects interest in therapies addressing body weight alongside joint symptoms and metabolic risk.
- Obesity and overweight
- Type 2 diabetes mellitus
- Cardiometabolic risk reduction
- Weight-related osteoarthritis
This area connects metabolic treatment strategies with outcomes in cardiovascular health and joint pain.
Neurology, dermatology, and preventive care
Randi Brechmann also contributes to research in migraine, Alzheimer’s disease, acne vulgaris, acne-related skin disease, and HPV vaccination. These studies broaden the therapeutic scope into neurologic, cutaneous, and infectious disease prevention domains.
- Chronic migraine and episodic migraine
- Alzheimer’s disease
- Acne vulgaris
- HPV-related cancer prevention
Additional interests include neurodegenerative disease management and preventive immunization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.